The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Danilova N.V.

Lomonosov Moscow State University

Bunga O.D.

Lomonosov Moscow State University — Medical Research and Educational Institute

Polushkina T.V.

Lomonosov Moscow State University

On the 60th anniversary of the P. Lauren’s classification of histological types of gastric cancer

Authors:

Danilova N.V., Bunga O.D., Polushkina T.V.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2025;87(4): 68‑75

DOI: 10.17116/patol20258704168

Read: 520 times

Download PDF (RU)
Contact the author
Table of contents

ON THE 60TH ANNIVERSARY OF THE P. LAUREN’S CLASSIFICATION OF HISTOLOGICAL TYPES OF GASTRIC CANCER
ON THE 60TH ANNIVERSARY OF THE P. LAUREN’S CLASSIFICATION OF HISTOLOGICAL TYPES OF GASTRIC CANCER

To cite this article:

Danilova NV, Bunga OD, Polushkina TV. On the 60th anniversary of the P. Lauren’s classification of histological types of gastric cancer. Russian Journal of Archive of Pathology. 2025;87(4):68‑75. (In Russ.)
https://doi.org/10.17116/patol20258704168

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Microsatellite instability as a possible diagnostic marker of the gastric mucosa dysplasia. Russian Journal of Archive of Pathology. 2025;(3):5-16
Prognostic significance and comparison of methods for calculating tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(3):17-25
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Expe­rience of successful treatment of leaks of high esophageal-intestinal anastomoses after gastrectomy by means of video-assisted thoracoscopic debridement and cycles of vacuum active aspi­ration system. P.A. Herzen Journal of Onco­logy. 2024;(6):63-69
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Study of serum cyto­kine concentration in primary patients with gastric cancer. P.A. Herzen Journal of Onco­logy. 2025;(2):25-29
Total gastrectomy with preserving duodenal passage by double tract reco­nstruction in patients with gastric cancer. Piro­gov Russian Journal of Surgery. 2025;(6):35-43
Technical aspe­cts of lapa­roscopic formation of gastroduodenoanastomosis (Billroth-I) during distal rese­ction in patients with gastric cancer. Endo­scopic Surgery. 2025;(3):44-51
Abstract:

The epidemiological data on the incidence of gastric cancer and its mortality make it a challenge for oncologists to find new and improve existing diagnostic methods and therapies. Despite the active change of modern realities in the practice of pathomorphologist for 60 years remains unchanged authority of the P.Laurén classification of histological main types. This does not leave it without attention from the scientists of our time, so there are published works refuting or confirming its prognostic significance, as well as studies in which its modifications are proposed. In this regard, the purpose of this review is to briefly systematise the currently available information on P.Laurén classification and to provide an opportunity to review the content of the original article by Pekka Laurén in Russian.

Keywords:

gastric cancer
histological classification
diffuse type
intestinal type

Authors:

Danilova N.V.

Lomonosov Moscow State University

Bunga O.D.

Lomonosov Moscow State University — Medical Research and Educational Institute

Polushkina T.V.

Lomonosov Moscow State University

Received:

27.12.2024

Accepted:

29.04.2025

Close metadata

References:

  1. Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J, Laversanne M, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. eClinicalMedicine. 2022:47:101404. https://doi.org/10.1016/j.eclinm.2022.101404
  2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965:64:31-49.  https://doi.org/10.1111/apm.1965.64.1.31
  3. Jiménez Fonseca P, Carmona-Bayonas A, Hernández R, Custodio A, Cano JM, Lacalle A, Echavarria I, Macias I, Mangas M, Visa L, et al. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry. Br J Cancer. 2017:117(6):775-782.  https://doi.org/10.1038/bjc.2017.245
  4. Cheng X, Yu S, Wang Y, Cui Y, Li W, Yu Y, Tang C, Jiang H, Ji Y, Sun Y, et al. The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric adenocarcinoma after D2 gastrectomy: a real-world study. Gastric Cancer. 2019:22(3):587-597.  https://doi.org/10.1007/s10120-018-0895-x
  5. Wang K, Li E, Busuttil RA, Kong JC, Pattison S, Sung JJY, Yu J, El-Omar EM, Simpson JA, Boussioutas A. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer. Ther Adv Med Oncol. 2020:12:1758835920930359. https://doi.org/10.1177/1758835920930359
  6. Zheng Z, Jin X, He Q, Lin B, Su H, Chen H, Fei S, Fei Z, Chen G, Pan H, et al. The efficacy of taxanes-and oxaliplatin-based chemotherapy in the treatment of gastric cancer after D2 gastrectomy for different Lauren types. Medicine (Baltimore). 2016:95(6):e2785. https://doi.org/10.1097/MD.0000000000002785
  7. Zurlo IV, Basso M, Strippoli A, Calegari MA, Orlandi A, Cassano A, Di Salvatore M, Garufi G, Bria E, Tortora G, et al. Treatment of locally advanced gastric cancer (LAGC): back to Lauren’s classification in pan-cancer analysis era? Cancers (Basel). 2020:12(7):1749. https://doi.org/10.3390/cancers12071749
  8. Li R, Zhang H, Cao Y, Liu X, Chen Y, Qi Y, Wang J, Yu K, Lin C, Liu H, et al. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer. Cancer Immunol Immunother. 2020:69(7):1327-1336. https://doi.org/10.1007/s00262-020-02550-7
  9. Pernot S, Terme M, Radosevic-Robin N, Castan F, Badoual C, Marcheteau E, Penault-Llorca F, Bouche O, Bennouna J, Francois E, et al. Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance. Gastric Cancer. 2020:23(1):73-81.  https://doi.org/10.1007/s10120-019-00983-3
  10. Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int J Clin Oncol. 2019:24(7):771-778.  https://doi.org/10.1007/s10147-019-01443-9
  11. Tan Y, Chen Q, Pan S, An W, Xu H, Xing Y, Zhang J. LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway. BMC Cancer. 2022:22(1):474.  https://doi.org/10.1186/s12885-022-09541-0
  12. Chen W, Guo Q, Zhang H, Du Y, Zhou Y, Huang Z, Zhang M, Qin S. Differentially expressed microRNA in prognosis of gastric cancer with Lauren classification. Cancer Biomark. 2024:41(1):41-54.  https://doi.org/10.3233/cbm-230303
  13. Li X, Zhu X, Wang Y, Wang R, Wang L, Zhu ML, Zheng L. Prognostic value and association of Lauren classification with vegf and vegfr-2 expression in gastric cancer. Oncol Lett. 2019:18(5):4891-4899. https://doi.org/10.3892/ol.2019.10820
  14. Nam S, Lee Y. Genome-scale metabolic model analysis of metabolic differences between Lauren diffuse and intestinal subtypes in gastric cancer. Cancers. 2022:14(9):2340. https://doi.org/10.3390/cancers14092340
  15. Tang CT, Zeng L, Yang J, Zeng C, Chen Y. Analysis of the incidence and survival of gastric cancer based on the Lauren classification: a large population-based study using SEER. Front Oncol. 2020:10:01212. https://doi.org/10.3389/fonc.2020.01212
  16. Tang D, Ni M, Zhu H, Cao J, Zhou L, Shen S, Peng C, Lv Y, Xu G, Wang L, et al. Differential prognostic implications of gastric adenocarcinoma based on Lauren’s classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study. Ann Transl Med. 2021:9(8):646.  https://doi.org/10.21037/atm-20-7953
  17. Moore JL, Davies AR, Santaolalla A, Van Hemelrijck M, Maisey N, Lagergren J, Gossage JA, Kelly M, Baker CR, Jacques A, et al. Clinical relevance of the tumor location-modified Laurén classification system for gastric cancer in a Western population. Ann Surg Oncol. 2022:29(6):3911-3920. https://doi.org/10.1245/s10434-021-11252-y
  18. Ning FL, Zhang NN, Wang J, Jin YF, Quan HG, Pei JP, Zhao Y, Zeng XT, Abe M, Zhang CD. Prognostic value of modified Lauren classification in gastric cancer. World J Gastrointest Oncol. 2021:13(9):1184-1195. https://doi.org/10.4251/wjgo.v13.i9.1184
  19. Choi JK, Park YS, Jung DH, Son SY, Ahn SH, Park DJ, Kim HH. Clinical relevance of the tumor location-modified Lauren classification system of gastric cancer. J Gastric Cancer. 2015:15(3): 183-190.  https://doi.org/10.5230/jgc.2015.15.3.183
  20. Zhao LY, Wang JJ, Zhao YL, Chen XZ, Yang K, Chen XL, Zhang WH, Liu K, Song XH, Zheng JB, et al. Superiority of tumor location-modified Lauren classification system for gastric cancer: a multi-institutional validation analysis. Ann Surg Oncol. 2018:25(11):3257-3263. https://doi.org/10.1245/s10434-018-6654-8
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.